Xtant Medical Stock Price, News & Analysis (NYSEAMERICAN:XTNT)

$0.58 0.00 (0.00 %)
(As of 12/14/2017 04:47 AM ET)
Previous Close$0.58
Today's Range$0.58 - $0.62
52-Week Range$0.29 - $1.21
Volume65,500 shs
Average Volume570,464 shs
Market Capitalization$11.34 million
P/E RatioN/A
Dividend YieldN/A

About Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.

Receive XTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for XTNT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS($1.64)
Net IncomeN/A
Net Margins-43.03%
Return on EquityN/A
Return on Assets-25.99%


Outstanding Shares18,170,000

Xtant Medical (NYSEAMERICAN:XTNT) Frequently Asked Questions

What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings Inc (NYSEAMERICAN:XTNT) issued its quarterly earnings data on Tuesday, May, 9th. The medical device company reported ($0.29) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.30) by $0.01. The medical device company earned $22.08 million during the quarter. View Xtant Medical's Earnings History.

Where is Xtant Medical's stock going? Where will Xtant Medical's stock price be in 2017?

1 analysts have issued 1 year price objectives for Xtant Medical's stock. Their forecasts range from $1.50 to $1.50. On average, they anticipate Xtant Medical's stock price to reach $1.50 in the next twelve months. View Analyst Ratings for Xtant Medical.

Are investors shorting Xtant Medical?

Xtant Medical saw a drop in short interest in the month of November. As of November 30th, there was short interest totalling 1,017,329 shares, a drop of 9.8% from the November 15th total of 1,128,037 shares. Based on an average trading volume of 286,617 shares, the short-interest ratio is currently 3.5 days. Currently, 7.9% of the company's stock are sold short.

Who are some of Xtant Medical's key competitors?

Who are Xtant Medical's key executives?

Xtant Medical's management team includes the folowing people:

  • Kent L. Swanson, Independent Chairman of the Board (Age 70)
  • Carl D. O'Connell, President, Chief Executive Officer (Age 53)
  • Darrel Lee Holmes, Chief Operating Officer (Age 62)
  • Gregory Juda Ph.D., Chief Scientific Officer (Age 39)
  • David Louis Kirschman M.D., Director (Age 55)
  • Paul R. Buckman, Independent Director (Age 61)
  • John Deedrick, Independent Director (Age 52)
  • Michael A. Lopach CPA, Independent Director (Age 66)
  • Rudy A. Mazzocchi, Independent Director (Age 57)

How do I buy Xtant Medical stock?

Shares of Xtant Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Xtant Medical's stock price today?

One share of Xtant Medical stock can currently be purchased for approximately $0.58.

How big of a company is Xtant Medical?

Xtant Medical has a market capitalization of $11.34 million.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The medical device company can be reached via phone at +1-406-3880480.

MarketBeat Community Rating for Xtant Medical (XTNT)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  27 (Vote Underperform)
Total Votes:  77
MarketBeat's community ratings are surveys of what our community members think about Xtant Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Xtant Medical (NYSEAMERICAN:XTNT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.50$2.50$5.25$5.25
Price Target Upside: 303.23% upside458.78% upside1,073.45% upside1,073.45% upside

Xtant Medical (NYSEAMERICAN:XTNT) Consensus Price Target History

Price Target History for Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical (NYSEAMERICAN:XTNT) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
11/22/2017Maxim GroupReiterated RatingBuy$1.50View Rating Details
11/30/2016AegisInitiated CoverageBuy$3.50View Rating Details
8/4/2016HC WainwrightReiterated RatingBuyView Rating Details
3/17/2016Brean CapitalReiterated RatingBuy$10.00View Rating Details
(Data available from 12/14/2015 forward)


Xtant Medical (NYSEAMERICAN:XTNT) Earnings History and Estimates Chart

Earnings by Quarter for Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical (NYSEAMERICAN XTNT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/9/2017Q1 2017($0.30)($0.29)$22.08 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.30)($0.31)$24.45 million$24.47 millionViewListenView Earnings Details
5/4/2016Q1($0.39)($0.44)$21.94 million$20.98 millionViewN/AView Earnings Details
3/15/2016Q415($0.22)$0.97$23.34 million$22.30 millionViewN/AView Earnings Details
11/11/2015Q3($0.15)($0.64)$19.64 million$17.69 millionViewListenView Earnings Details
8/12/2015($0.29)($0.41)ViewN/AView Earnings Details
3/17/2015Q414($0.35)($0.46)$8.90 million$9.10 millionViewN/AView Earnings Details
11/5/2014($0.23)($0.19)ViewN/AView Earnings Details
8/12/2014Q214($0.47)($0.35)$8.85 million$5.60 millionViewN/AView Earnings Details
5/6/2014Q114($0.04)($0.08)$9.73 million$8.90 millionViewN/AView Earnings Details
3/19/2014Q413($0.07)($0.08)$8.00 million$8.30 millionViewN/AView Earnings Details
5/9/2013Q1 2013($0.06)($0.04)ViewN/AView Earnings Details
11/7/2012Q312($0.04)($0.06)$9.29 million$8.90 millionViewN/AView Earnings Details
8/9/2012($0.05)$0.02ViewN/AView Earnings Details
5/3/2012($0.04)($0.03)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Xtant Medical (NYSEAMERICAN:XTNT) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for Xtant Medical (NYSEAMERICAN:XTNT)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Xtant Medical (NYSEAMERICAN XTNT) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Xtant Medical (NYSEAMERICAN:XTNT)
Insider Trades by Quarter for Xtant Medical (NYSEAMERICAN:XTNT)

Xtant Medical (NYSEAMERICAN XTNT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/9/2016Daniel S GoldbergerCEOBuy5,000$2.34$11,700.00View SEC Filing  
12/3/2015Kent L. SwansonDirectorBuy3,300$2.83$9,339.00View SEC Filing  
11/20/2015David Louis KirschmanEVPBuy2,000$2.99$5,980.00View SEC Filing  
11/20/2015Kent L. SwansonDirectorBuy5,000$3.00$15,000.00View SEC Filing  
11/19/2015David Louis KirschmanEVPBuy2,000$2.90$5,800.00View SEC Filing  
11/16/2015Daniel S GoldbergerCEOBuy3,000$2.80$8,400.00View SEC Filing  
9/4/2015Daniel S GoldbergerCEOBuy81,522$3.68$300,000.96View SEC Filing  
9/4/2015Jon M WickwireDirectorBuy10,869$3.68$39,997.92View SEC Filing  
5/22/2014Daniel S GoldbergerCEOBuy25,000$0.65$16,250.00View SEC Filing  
5/20/2014Gregory Alexander JudaInsiderBuy20,000$0.69$13,800.00View SEC Filing  
5/7/2014Guy S CookMajor ShareholderSell1,365,000$0.66$900,900.00View SEC Filing  
5/6/2014Guy S CookMajor ShareholderSell885,000$0.75$663,750.00View SEC Filing  
5/2/2014Guy S CookMajor ShareholderSell280,000$0.73$204,400.00View SEC Filing  
4/30/2014Guy S CookMajor ShareholderSell85,000$0.70$59,500.00View SEC Filing  
4/25/2014Guy S CookMajor ShareholderSell100,000$0.70$70,000.00View SEC Filing  
4/24/2014Guy S CookMajor ShareholderSell390,000$0.70$273,000.00View SEC Filing  
4/22/2014Guy S CookMajor ShareholderSell410,000$0.71$291,100.00View SEC Filing  
4/17/2014Guy S CookMajor ShareholderSell75,000$0.70$52,500.00View SEC Filing  
4/9/2014Guy S CookMajor ShareholderSell410,000$0.72$295,200.00View SEC Filing  
1/15/2014Guy S CookMajor ShareholderBuy160,000$0.64$102,400.00View SEC Filing  
1/7/2014Guy S CookMajor ShareholderSell273,300$0.53$144,849.00View SEC Filing  
12/26/2013Guy S CookMajor ShareholderSell64,380$0.53$34,121.40View SEC Filing  
12/24/2013Guy S CookMajor ShareholderSell300,000$0.44$132,000.00View SEC Filing  
12/11/2013Guy S CookMajor ShareholderSell160,000$0.42$67,200.00View SEC Filing  
11/19/2013Gregory Alexander JudaInsiderBuy20,000$0.45$9,000.00View SEC Filing  
11/12/2013Daniel S GoldbergerCEOBuy50,000$0.48$24,000.00View SEC Filing  
9/20/2013Guy S CookMajor ShareholderSell30,000$0.60$18,000.00View SEC Filing  
9/13/2013Darrel Lee HolmesCOOSell30,000$0.57$17,100.00View SEC Filing  
8/28/2013Guy S CookMajor ShareholderSell400,000$0.56$224,000.00View SEC Filing  
8/26/2013Daniel S GoldbergerCEOBuy20,000$0.60$12,000.00View SEC Filing  
8/19/2013Daniel S GoldbergerCEOBuy16,194$0.59$9,554.46View SEC Filing  
8/16/2013Daniel S GoldbergerCEOBuy13,806$0.58$8,007.48View SEC Filing  
6/18/2013Guy S CookMajor ShareholderSell372,859$0.52$193,886.68View SEC Filing  
6/13/2013Guy S CookMajor ShareholderSell175,000$0.55$96,250.00View SEC Filing  
6/13/2013Kent L SwansonDirectorBuy100,000$0.55$55,000.00View SEC Filing  
6/12/2013Guy S CookMajor ShareholderSell2,600$0.55$1,430.00View SEC Filing  
6/11/2013Guy S CookMajor ShareholderSell21,000$0.56$11,760.00View SEC Filing  
6/10/2013Guy S CookMajor ShareholderSell13,400$0.56$7,504.00View SEC Filing  
6/7/2013Guy S CookMajor ShareholderSell88,000$0.56$49,280.00View SEC Filing  
9/11/2012Guy S CookCEOBuy5,000$1.71$8,550.00View SEC Filing  
(Data available from 1/1/2013 forward)


Xtant Medical (NYSEAMERICAN XTNT) News Headlines

Xtant Medical Holdings Inc (XTNT) Short Interest UpdateXtant Medical Holdings Inc (XTNT) Short Interest Update
www.americanbankingnews.com - December 12 at 1:50 AM
Short Interest in Xtant Medical Holdings Inc (XTNT) Declines By 1.0%Short Interest in Xtant Medical Holdings Inc (XTNT) Declines By 1.0%
www.americanbankingnews.com - November 28 at 1:04 AM
Maxim Group Reaffirms "Buy" Rating for Xtant Medical Holdings Inc (XTNT)Maxim Group Reaffirms "Buy" Rating for Xtant Medical Holdings Inc (XTNT)
www.americanbankingnews.com - November 23 at 3:18 PM
Xtant Medical Holdings Inc (XTNT) Sees Significant Drop in Short InterestXtant Medical Holdings Inc (XTNT) Sees Significant Drop in Short Interest
www.americanbankingnews.com - November 14 at 6:02 PM

SEC Filings

Xtant Medical (NYSEAMERICAN:XTNT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Xtant Medical (NYSEAMERICAN:XTNT) Income Statement, Balance Sheet and Cash Flow Statement


Xtant Medical (NYSEAMERICAN XTNT) Stock Chart for Thursday, December, 14, 2017

Loading chart…

This page was last updated on 12/14/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.